Concourse Financial Group Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72
| Closed | -$8.34K | – | 4686 |
|
|
2024
Q4 | $8.34K | Hold |
72
| – | – | ﹤0.01% | 1758 |
|
|
2024
Q3 | $7.21K | Hold |
72
| – | – | ﹤0.01% | 1772 |
|
|
2024
Q2 | $6.07K | Hold |
72
| – | – | ﹤0.01% | 1822 |
|
|
2024
Q1 | $5.26K | Hold |
72
| – | – | ﹤0.01% | 1870 |
|
|
2023
Q4 | $5.14K | Hold |
72
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q3 | $4.31K | Hold |
72
| – | – | ﹤0.01% | 1849 |
|
|
2023
Q2 | $5.19K | Sell |
72
-15
| -17% | -$1.08K | ﹤0.01% | 1820 |
|
|
2023
Q1 | $6.4K | Hold |
87
| – | – | ﹤0.01% | 1800 |
|
|
2022
Q4 | $5.81K | Sell |
87
-52
| -37% | -$3.47K | ﹤0.01% | 1811 |
|
|
2022
Q3 | $7K | Hold |
139
| – | – | ﹤0.01% | 1568 |
|
|
2022
Q2 | $8K | Hold |
139
| – | – | ﹤0.01% | 1729 |
|
|
2022
Q1 | $10K | Hold |
139
| – | – | ﹤0.01% | 1687 |
|
|
2021
Q4 | $13K | Hold |
139
| – | – | ﹤0.01% | 1779 |
|
|
2021
Q3 | $12K | Hold |
139
| – | – | ﹤0.01% | 1832 |
|
|
2021
Q2 | $11K | Hold |
139
| – | – | ﹤0.01% | 1834 |
|
|
2021
Q1 | $13K | Hold |
139
| – | – | ﹤0.01% | 1688 |
|
|
2020
Q4 | $9K | Hold |
139
| – | – | ﹤0.01% | 1718 |
|
|
2020
Q3 | $8K | Hold |
139
| – | – | ﹤0.01% | 1648 |
|
|
2020
Q2 | $10K | Sell |
139
-223
| -62% | -$16K | ﹤0.01% | 1491 |
|
|
2020
Q1 | $16K | Sell |
362
-80
| -18% | -$3.54K | ﹤0.01% | 1320 |
|
|
2019
Q4 | $29K | Buy |
+442
| New | +$29K | ﹤0.01% | 1142 |
|
|
2019
Q3 | – | Sell |
-32
| Closed | -$2K | – | 3911 |
|
|
2019
Q2 | $2K | Sell |
32
-160
| -83% | -$10K | ﹤0.01% | 2003 |
|
|
2019
Q1 | $15K | Sell |
192
-45
| -19% | -$3.52K | ﹤0.01% | 1370 |
|
|
2018
Q4 | $20K | Buy |
237
+173
| +270% | +$14.6K | ﹤0.01% | 1149 |
|
|
2018
Q3 | $11K | Buy |
+64
| New | +$11K | ﹤0.01% | 1064 |
|